135 related articles for article (PubMed ID: 18209733)
1. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses.
Hendrie PC; Huo Y; Stolitenko RB; Russell DW
Mol Ther; 2008 Mar; 16(3):534-40. PubMed ID: 18209733
[TBL] [Abstract][Full Text] [Related]
2. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
3. Proviruses with Long-Term Stable Expression Accumulate in Transcriptionally Active Chromatin Close to the Gene Regulatory Elements: Comparison of ASLV-, HIV- and MLV-Derived Vectors.
Miklík D; Šenigl F; Hejnar J
Viruses; 2018 Mar; 10(3):. PubMed ID: 29517993
[TBL] [Abstract][Full Text] [Related]
4. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
5. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
6. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 long terminal repeat promoter regulated dual reporter: potential use in screening of transcription modulators.
Ravi DS; Mitra D
Anal Biochem; 2007 Jan; 360(2):315-7. PubMed ID: 17141170
[No Abstract] [Full Text] [Related]
8. Lack of correlation between basal expression levels and susceptibility to transcriptional shutdown among single-gene murine leukemia virus vector proviruses.
Duch M; Paludan K; Jørgensen P; Pedersen FS
J Virol; 1994 Sep; 68(9):5596-601. PubMed ID: 8057440
[TBL] [Abstract][Full Text] [Related]
9. Optimization of regulated LTR-mediated expression.
Lorens JB; Jang Y; Rossi AB; Payan DG; Bogenberger JM
Virology; 2000 Jun; 272(1):7-15. PubMed ID: 10873744
[TBL] [Abstract][Full Text] [Related]
10. Optimization of transcriptional regulatory elements for constructing plasmid vectors.
Xu ZL; Mizuguchi H; Ishii-Watabe A; Uchida E; Mayumi T; Hayakawa T
Gene; 2001 Jul; 272(1-2):149-56. PubMed ID: 11470520
[TBL] [Abstract][Full Text] [Related]
11. Prostate-specific antigen promoter/enhancer driven gene therapy for prostate cancer: construction and testing of a tissue-specific adenovirus vector.
Latham JP; Searle PF; Mautner V; James ND
Cancer Res; 2000 Jan; 60(2):334-41. PubMed ID: 10667585
[TBL] [Abstract][Full Text] [Related]
12. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
[TBL] [Abstract][Full Text] [Related]
13. Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.
Jang J; Lee JT; Lee K; Kim S; Kim JY; Yoon K; Kim S
Gene Ther; 2011 Mar; 18(3):240-9. PubMed ID: 20944681
[TBL] [Abstract][Full Text] [Related]
14. [Construction of kir3dl1 promoter expression vector and its activity in K562 cell line].
Gao XN; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):258-62. PubMed ID: 18426644
[TBL] [Abstract][Full Text] [Related]
15. RNA 3' readthrough of oncoretrovirus and lentivirus: implications for vector safety and efficacy.
Zaiss AK; Son S; Chang LJ
J Virol; 2002 Jul; 76(14):7209-19. PubMed ID: 12072520
[TBL] [Abstract][Full Text] [Related]
16. Inefficiency of expression of luciferase reporter from transfected murine leukaemia proviral DNA may be partially overcome by providing a strong polyadenylation signal.
Maxwell IH; Brown JL; Maxwell F
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1721-4. PubMed ID: 1649905
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1.
Stitz J; Buchholz CJ; Engelstädter M; Uckert W; Bloemer U; Schmitt I; Cichutek K
Virology; 2000 Jul; 273(1):16-20. PubMed ID: 10891403
[TBL] [Abstract][Full Text] [Related]
18. Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells.
Wang JM; Zheng H; Sugahara Y; Tan J; Yao SN; Olson E; Kurachi K
Hum Gene Ther; 1996 Sep; 7(14):1743-56. PubMed ID: 8886845
[TBL] [Abstract][Full Text] [Related]
19. Topological constraints governing the use of the chicken HS4 chromatin insulator in oncoretrovirus vectors.
Yannaki E; Tubb J; Aker M; Stamatoyannopoulos G; Emery DW
Mol Ther; 2002 May; 5(5 Pt 1):589-98. PubMed ID: 11991750
[TBL] [Abstract][Full Text] [Related]
20. Genetic reshuffling reconstitutes functional expression cassettes in retroviral vectors.
Tabotta W; Klein D; Hohenadl C; Salmons B; Günzburg WH
J Gene Med; 2001; 3(5):418-26. PubMed ID: 11601755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
